Royal Marsden Hospital

A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.

• Royal Marsden Hospital

  London, SW3 6JJ

  64 vizsgálat

• Royal Marsden Hospital

  Sutton, Surrey SM2 5PT

  64 vizsgálat

• The Royal Marsden Hospital

  London, SW3 6JJ

  29 vizsgálat

• Royal Marsden Hospital (Sutton)

  Sutton, SM2 5PT

  23 vizsgálat

• The Royal Marsden Hospital

  Sutton, SM2 5PT

  23 vizsgálat

• Royal Marsden Hospital (Sutton)

  London, SM2 5PT

  16 vizsgálat

• Royal Marsden Hospital (Chelsea)

  London, Kensington and Chelsea SW3 6JJ

  15 vizsgálat

• Royal Marsden Hospital - London

  London, SW3 6JJ

  13 vizsgálat

• The Royal Marsden Hospital, Chelsea

  London, SW3 6JJ

  10 vizsgálat

• The Royal Marsden Hospital, Sutton

  Sutton, SM2 5PT

  9 vizsgálat

• Royal Marsden Hospital

  Chelsea, England SW36JJ

  5 vizsgálat

• Royal Marsden Hospital - Fulham

  London, SW3 6JJ

  5 vizsgálat

• Royal Marsden Hospital - Surrey

  Sutton, Surrey SM2 5PT

  5 vizsgálat

• The Royal Marsden Hospital (Surrey)

  Sutton, Queensland SM2 5PT

  5 vizsgálat

• Royal Marsden Hospital

  Surrey, SM2 5PT

  2 vizsgálat

  • NCT05438043A Study of Daratumumab

  • NCT03277105A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma

• Royal Marsden Hospital - Surrey

  Surrey Quays, SM2 5PT

  2 vizsgálat

  • NCT04501614A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

  • NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

    Contact: Emma (Xiaoning) Cai

• The Royal Marsden Hospital - Drug Development Unit

  Sutton, SM2 5PT

  2 vizsgálat

  • NCT066302605G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours

    Contact: Juanita Lopez, MD, PhD

  • NCT066322365G-EMERALD: Amivantamab in Malignant Brain Tumours

• The Royal Marsden Hospital- London

  London, 6JJ

  2 vizsgálat

  • NCT05323656A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

  • NCT04675333Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)

• Cancer Genetics Unit, Royal Marsden Hospital

  London, Sutton, Surrey SM2 5PT

  1 vizsgálat

  • NCT05097274The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.

    Contact: Rosalind Eeles, MA; PhD; FRCP; FRCR; FMedSci

• Cancer Genetics Unit, Royal Marsden Hospital

  Sutton, Surrey SM2 5PT

  1 vizsgálat

  • NCT00261456The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer

• Head and Neck Unit, Royal Marsden Hospital

  London, SW3 6JJ

  1 vizsgálat

  • NCT05808920The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck

    Contact: Vishak Muraleedharan Shylaja

• Pharmacy: Royal Marsden Hospital

  Sutton, Surrey SM2 5PT

  1 vizsgálat

  • NCT05208762A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

• Royal Marsden Hospital

  Kingston upon Thames, KT2 7QB

  1 vizsgálat

  • NCT03782207A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice

• Royal Marsden Hospital

  Skerray, SM2 5PT

  1 vizsgálat

  • NCT06919965A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

• ROYAL MARSDEN HOSPITAL (CHELSEA)-Gynaecology Research Centre (Site 2807)

  London, England SW10 9NH

  1 vizsgálat

  • NCT06459180A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

• ROYAL MARSDEN HOSPITAL (CHELSEA)-Gynaecology Research Centre (Site 4002)

  London, England SW3 6JJ

  1 vizsgálat

  • NCT06132958Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

• Royal Marsden Hospital - Chelsea, London

  London, SW3 6JJ

  1 vizsgálat

  • NCT02194842Phase III Radium 223 mCRPC-PEACE III

• ROYAL MARSDEN HOSPITAL (CHELSEA)-Lung Unit (Site 2075)

  London, Kensington and Chelsea SW3 6JJ

  1 vizsgálat

  • NCT06623422A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    Contact: Study Coordinator

• ROYAL MARSDEN HOSPITAL (CHELSEA) (Site 0283)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT04210115Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

• Royal Marsden Hospital - Chelsea (Site #0505)

  London, SW3 6JJ

  1 vizsgálat

  • NCT06788990FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

    Contact: Principal Investigator

• ROYAL MARSDEN HOSPITAL (CHELSEA) (Site 0701)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT04221945Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

• ROYAL MARSDEN HOSPITAL (CHELSEA) (Site 1201)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT05562830A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

• ROYAL MARSDEN HOSPITAL (CHELSEA) (Site 1403)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT04776148Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)

• ROYAL MARSDEN HOSPITAL (CHELSEA) (Site 1804)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT05933577A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

• ROYAL MARSDEN HOSPITAL (CHELSEA) (Site 2606)

  London, Kensington and Chelsea SW3 6JJ

  1 vizsgálat

  • NCT06074588Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

• ROYAL MARSDEN HOSPITAL (CHELSEA) (Site 2801)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT06824467A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

    Contact: Study Coordinator

• ROYAL MARSDEN HOSPITAL (CHELSEA) (Site 2806)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT05173987Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

• ROYAL MARSDEN HOSPITAL (CHELSEA) (Site 3201)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT05845814A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)

• ROYAL MARSDEN HOSPITAL (CHELSEA) (Site 4006)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT06952504A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    Contact: Study Coordinator

• Royal Marsden Hospital Department of Medicine

  London, SW3 6JJ

  1 vizsgálat

  • NCT03869892Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.

• Royal Marsden Hospital Department of Medicine

  Sutton, SM2 5PT

  1 vizsgálat

  • NCT03869892Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.

• Royal Marsden Hospital;Dept of Med-Onc

  London, SW3 6JJ

  1 vizsgálat

  • NCT04929223A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

• Royal Marsden Hospital - Drug Development Unit

  Sutton, London SM2 5NG

  1 vizsgálat

  • NCT06976892Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer

    Contact: Prof Udai Banerji, MBBS MD DNB PhD FRCP

• Royal Marsden Hospital (Fulham Road)

  London

  1 vizsgálat

  • NCT03762018BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma

• Royal Marsden Hospital - Fulham Road London (Site 0613)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT03553836Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

• Royal Marsden Hospital - Fulham Road London (Site 1609)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT03765918Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

• Royal Marsden Hospital;Institute of Cancer Research

  Sutton, SM2 5PT

  1 vizsgálat

  • NCT02500407A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

• Royal Marsden Hospital - Institute of Cancer Research - Chelsea

  London, SM2 7LN

  1 vizsgálat

  • NCT04382664UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma

• Royal Marsden Hospital - London, Department of Medical Oncology

  London

  1 vizsgálat

  • NCT05501886Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

• Royal Marsden Hospital (Site 0402)

  Fulham, England SW3 6JJ

  1 vizsgálat

  • NCT06843447A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003).

    Contact: Study Coordinator

• Royal Marsden Hospital (Site 0457)

  Sutton, London, City of SM2 5PT

  1 vizsgálat

  • NCT03425643Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

• Royal Marsden Hospital (Site 0526)

  Sutton, England SM2 5PT

  1 vizsgálat

  • NCT03834519Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)

• Royal Marsden Hospital (Site 0536)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT04003636Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

• Royal Marsden Hospital. (Site 0901)

  Sutton, Surrey SM2 5PT

  1 vizsgálat

  • NCT04428151Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

• Royal Marsden Hospital (Site 0902)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT04428151Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

• Royal Marsden Hospital (Site 1510)

  Sutton, Surrey SM2 5PT

  1 vizsgálat

  • NCT03615326Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

• Royal Marsden Hospital (Site 2904)

  Sutton, London, City of SM2 5PT

  1 vizsgálat

  • NCT04199104A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)

• Royal Marsden Hospital (Site 3347)

  Sutton, SM2 5PT

  1 vizsgálat

  • NCT06941272A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

    Contact: Study Coordinator

• Royal Marsden Hospital - site: Chelsea, London

  London, SW3 6JJ

  1 vizsgálat

  • NCT04498767Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)

    Contact: EORTC HQ

• Royal Marsden Hospital - site: Sutton, Surrey

  Sutton, SM2 5PT

  1 vizsgálat

  • NCT02205047Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma

• Royal Marsden Hospital - Surrey

  London, SW7 3RP

  1 vizsgálat

  • NCT05152147A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

• Royal Marsden Hospital - Sutton

  Surrey Quays, SM2 5PT

  1 vizsgálat

  • NCT06112314IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

• Royal Marsden Hospital (Sutton)-Drug Development Unit (Site 1347)

  Sutton, Surrey SM2 5PT

  1 vizsgálat

  • NCT06395103Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

    Contact: Study Coordinator

• Royal Marsden Hospital (Sutton)-Gynaecology Unit (Site 0696)

  London, Surrey SM3 5PT

  1 vizsgálat

  • NCT04221945Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)

• Royal Marsden Hospital (Sutton)-Gynaecology Unit (Site 2801)

  Sutton, England SM2 5PT

  1 vizsgálat

  • NCT06459180A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)

• Royal Marsden Hospital (Sutton)-Gynaecology Unit (Site 4010)

  London, Sutton SW3 6JJ

  1 vizsgálat

  • NCT06132958Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

• Royal Marsden Hospital (Sutton) (Site 0281)

  Sutton, Surrey SM2 5PT

  1 vizsgálat

  • NCT04210115Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

• Royal Marsden Hospital (Sutton) (Site 0741)

  London, Surrey SM3 5PT

  1 vizsgálat

  • NCT06863272A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

    Contact: Study Coordinator

• Royal Marsden Hospital (Sutton) (Site 0800)

  London, Surrey SM3 5PT

  1 vizsgálat

  • NCT03797326Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

• Royal Marsden Hospital (Sutton) (Site 0922)

  Sutton, London, City of SM2 5PT

  1 vizsgálat

  • NCT06925737A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

    Contact: Study Coordinator

• Royal Marsden Hospital (Sutton) (Site 1407)

  London, Surrey SM3 5PT

  1 vizsgálat

  • NCT04380636Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

• Royal Marsden Hospital (Sutton) (Site 1409)

  London, Surrey SM3 5PT

  1 vizsgálat

  • NCT04776148Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)

• Royal Marsden Hospital (Sutton) (Site 2076)

  London, London, City of SW3 6JJ

  1 vizsgálat

  • NCT06623422A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    Contact: Study Coordinator

• Royal Marsden Hospital (Sutton) (Site 2605)

  Sutton, Surrey SM2 5PT

  1 vizsgálat

  • NCT06074588Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

• Royal Marsden Hospital (Sutton) (Site 2802)

  Sutton, London, City of SM2 5PT

  1 vizsgálat

  • NCT06824467A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

    Contact: Study Coordinator

• Royal Marsden Hospital (Sutton) (Site 4005)

  London, Surrey SM3 5PT

  1 vizsgálat

  • NCT06952504A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

    Contact: Study Coordinator

• The Royal Marsden Hospital

  Chelsea

  1 vizsgálat

  • NCT05376891Met Non Small Cell Cancer Registry (MOMENT)

    Contact: Sanjay Popat (principal investigator)

• The Royal Marsden Hospital Chelsea

  Chelsea

  1 vizsgálat

  • NCT04550104A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC

    Contact: Merina Ahmed (principal investigator)

• The Royal Marsden Hospital - Chelsea Site

  London, SW3 6JJ

  1 vizsgálat

  • NCT05253651A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

• The Royal Marsden Hospital, Fulham

  London, SW3 6JJ

  1 vizsgálat

  • NCT03452137A Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck

• The Royal Marsden Hospital - Neuro-Oncology Unit

  Sutton, SM2 5PT

  1 vizsgálat

  • NCT066302605G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours

    Contact: Liam Welsh, MD

• The Royal Marsden Hospitals

  London

  1 vizsgálat

  • NCT05604963Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers

    Contact: Vinidh Paleri (principal investigator)

• The Royal Marsden Hospital (Surrey)

  Surrey Quays, SM25PT

  1 vizsgálat

  • NCT04907539A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC)

• The Royal Marsden Hospital - Surrey

  London, 5PT

  1 vizsgálat

  • NCT04675333Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)

• The Royal Marsden Hospital (Sutton and Chelsea)

  London, SM2 5PT

  1 vizsgálat

  • NCT07741929Patient and Provider Perspectives on Genetic Risk Profiling

    Contact: Tarryn Shaw, MSc Genetic Counselling